204 related articles for article (PubMed ID: 9785912)
21. Analysis of cell damage and proliferation in Helicobacter pylori-infected human gastric mucosa from patients with gastric adenocarcinoma.
Yabuki N; Sasano H; Tobita M; Imatani A; Hoshi T; Kato K; Ohara S; Asaki S; Toyota T; Nagura H
Am J Pathol; 1997 Sep; 151(3):821-9. PubMed ID: 9284831
[TBL] [Abstract][Full Text] [Related]
22. Role of Helicobacter pylori infection and chronic inflammation in gastric cancer in the cardia.
Egi Y; Ito M; Tanaka S; Imagawa S; Takata S; Yoshihara M; Haruma K; Chayama K
Jpn J Clin Oncol; 2007 May; 37(5):365-9. PubMed ID: 17578895
[TBL] [Abstract][Full Text] [Related]
23. [Helicobacter pylori and gastric cancer. The incidence of infection in personal experience].
Caputo S; Mosca F; Persi A; Ettaro G; Scaringi S; Russo G; Piazza D
Minerva Chir; 2002 Oct; 57(5):649-55. PubMed ID: 12370666
[TBL] [Abstract][Full Text] [Related]
24. [Peptic activity of gastric juice in chronic gastritis. Morpho-functional aspects].
Perasso A; Testino G; Cornaggia M; Melloni E
Minerva Med; 1993 Feb; 84(1-2):17-22. PubMed ID: 8464563
[TBL] [Abstract][Full Text] [Related]
25. Effect of Helicobacter pylori infection, age and epithelial cell turnover in a general population at high risk for gastric cancer.
Baldini L; Pretolani S; Bonvicini F; Miglio F; Epifanio G; Gentiloni Silveri N; Stefanelli ML; Bernardi M; Gasbarrini G
Panminerva Med; 1999 Sep; 41(3):187-92. PubMed ID: 10568114
[TBL] [Abstract][Full Text] [Related]
26. Difference of p53AIP1 mRNA expression in gastric mucosa between patients with gastric cancer and chronic gastritis infected with Helicobacter pylori.
Sawaya M; Yoshimura T; Shimoyama T; Munakata A; Fukuda S
J Clin Gastroenterol; 2008 Apr; 42(4):351-5. PubMed ID: 18277906
[TBL] [Abstract][Full Text] [Related]
27. Body-fundic mucopeptic cells expansion after Helicobacter pylori eradication.
Testino G
Am J Gastroenterol; 1998 Dec; 93(12):2636-8. PubMed ID: 9860460
[No Abstract] [Full Text] [Related]
28. [Helicobacter pylori and gastro-duodenal pathology].
Villani L; Fiocca R; Perego M; De Giacomo C; Trespi E; Alvisi C; Turpini R; Solcia E
Pathologica; 1990; 82(1082):707-17. PubMed ID: 2094841
[TBL] [Abstract][Full Text] [Related]
29. Expression of cell-cycle related proteins in Helicobacter pylori gastritis and association with gastric carcinoma.
Polat A; Cinel L; Dusmez D; Aydin O; Egilmez R
Neoplasma; 2002; 49(2):95-100. PubMed ID: 12088113
[TBL] [Abstract][Full Text] [Related]
30. Response of IgG1 and IgG2 subclasses to Helicobacter pylori in subjects with chronic inflammation of the gastric mucosa, atrophy and gastric cancer in a country with high Helicobacter pylori infection prevalence.
Vorobjova T; Ren Z; Dunkley M; Clancy R; Maaroos HI; Labotkin R; Kull K; Uibo R
APMIS; 2006 May; 114(5):372-80. PubMed ID: 16725014
[TBL] [Abstract][Full Text] [Related]
31. Gastric epithelial cell proliferation and cagA status in Helicobacter pylori gastritis at different gastric sites.
Cabral MM; Oliveira CA; Mendes CM; Guerra J; Queiroz DM; Rocha GA; Rocha AM; Nogueira AM
Scand J Gastroenterol; 2007 May; 42(5):545-54. PubMed ID: 17454874
[TBL] [Abstract][Full Text] [Related]
32. Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies.
Camorlinga-Ponce M; Flores-Luna L; Lazcano-Ponce E; Herrero R; Bernal-Sahagún F; Abdo-Francis JM; Aguirre-García J; Muñoz N; Torres J
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2498-504. PubMed ID: 18768521
[TBL] [Abstract][Full Text] [Related]
33. Gastric ghrelin expression associated with Helicobacter pylori infection and chronic gastritis in obese patients.
Liew PL; Lee WJ; Lee YC; Chen WY
Obes Surg; 2006 May; 16(5):612-9. PubMed ID: 16687031
[TBL] [Abstract][Full Text] [Related]
34. [Effect of Helicobacter pylori infection and eradication on proliferative kinetics of the gastric mucosa].
Unger Z; Prónai L; Szaleczky E; Zágoni T; Molnár B; Tulassay Z
Orv Hetil; 2000 Dec; 141(50):2695-700. PubMed ID: 11189675
[TBL] [Abstract][Full Text] [Related]
35. p53 evaluation in gastric mucosa of patients with chronic Helicobacter pylori infection.
Marinone C; Martinetti A; Mestriner M; Seregni E; Geuna M; Ferrari L; Strola G; Bonardi L; Fea E; Bombardieri E
Anticancer Res; 2001; 21(2A):1115-8. PubMed ID: 11396149
[TBL] [Abstract][Full Text] [Related]
36. Pathogenic implications of interleukin-8 activity and bacterial phenotype in antral gastritis associated with Helicobacter pylori.
Martín Guerrero JM; Hergueta Delgado P; Esteban Carretero JJ; Rivera Hueto FF; Pellicer Bautista FJ; Herrerías Gutiérrez JM
Rev Esp Enferm Dig; 2000 May; 92(5):301-15. PubMed ID: 10927930
[TBL] [Abstract][Full Text] [Related]
37. Role of concurrent S. mansoni infection in H. pylori-associated gastritis: a flow cytometric DNA-analysis and oxyradicals correlations.
Elshal MF; Elsayed IH; El Kady IM; Badra G; El-Refaei A; El-Batanony M; Hendy OM
Clin Chim Acta; 2004 Aug; 346(2):191-8. PubMed ID: 15256320
[TBL] [Abstract][Full Text] [Related]
38. [The effects of eradication therapy in patients with chronic atrophic gastritis and seropositivity for anti-HP antibodies and histological negativity for Helicobacter pylori].
Leri O; Mastropasqua M; Scopelliti G; Grasso E; Losi T; Iadicicco A; Perinelli P
Clin Ter; 1999; 150(5):343-6. PubMed ID: 10687264
[TBL] [Abstract][Full Text] [Related]
39. Helicobacter pylori infection affects the expression of PCNA, p53, c-erbB-2 and Bcl-2 in the human gastric mucosa.
Jorge O; Cuello Carrión FD; Jorge A; Ciocca DR
Rev Esp Enferm Dig; 2003 Feb; 95(2):97-104, 89-96. PubMed ID: 12760717
[TBL] [Abstract][Full Text] [Related]
40. Severity of atrophic gastritis related to antiparietal cell antibody and gastric carcinogenesis, including p53 mutations.
Taguchi A; Ohmiya N; Itoh A; Hirooka Y; Niwa Y; Mori N; Goto H
J Gastroenterol Hepatol; 2006 Mar; 21(3):545-51. PubMed ID: 16638096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
